Form 4: ACM Research Officer Exercises Options and Sells Shares Under Pre-Arranged Plan

Lisa Feng, an officer of ACM Research, Inc., executed a pre-planned transaction involving the exercise of stock options and the subsequent sale of Class A Common Stock.

Summary

• Lisa Feng, Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of ACM Research, Inc. (ACMR), reported transactions involving the company's Class A Common Stock.
• On June 24, 2025, Ms. Feng exercised a previously issued stock option to acquire 15,000 shares of Class A Common Stock at an exercise price of $5.60 per share.
• On the same date, she sold 15,000 shares of Class A Common Stock at a price of $26.00 per share.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Ms. Feng on March 12, 2025.
• Following these transactions, Ms. Feng directly holds 50,001 shares of Class A Common Stock and 45,000 unexercised stock options.

Sentiment

Score: 6

Explanation: The transaction represents a routine exercise of stock options and subsequent sale under a pre-arranged 10b5-1 trading plan, indicating a systematic approach to managing personal holdings rather than a reaction to new company developments. The insider realized a significant profit.

Positives

• The reporting person realized a significant profit from exercising stock options and selling the shares, indicating a successful personal investment strategy.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to managing personal holdings rather than a reaction to new, negative company information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by the market as a lack of confidence, although this is largely mitigated by the context of option exercise and the 10b5-1 plan.

Future Outlook

This SEC Form 4 filing details past insider transactions and does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This document reports a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.

Stakeholder Impact

• Shareholders: May view the insider sale with slight caution, but the pre-planned nature (Rule 10b5-1) and the context of option exercise generally mitigate concerns about management's confidence in the company's future.
• Employees: No direct impact from this specific transaction.

Key Dates

Recommendation

Keywords

ACM Research, ACMR, Form 4, insider trading, stock option exercise, share sale, 10b5-1 plan, executive compensation